Sihuan Pharmaceutical Holdings Group Ltd represents several core values and a strong corporate philosophy. As a leading pharmaceutical company in China, Sihuan Pharma is committed to delivering high-quality healthcare solutions to improve patients' lives. Their corporate philosophy revolves around innovation, integrity, and dedication. By focusing on research and development, Sihuan Pharma strives to introduce breakthrough drugs and contribute to medical advancements globally. With a customer-centric approach, the company ensures access to affordable medications while maintaining strict quality control standards. Sihuan Pharmaceutical Holdings Group Ltd's dedication to excellence and commitment to improving healthcare exemplify their core values and corporate philosophy.

Sihuan Pharmaceutical Holdings Group Ltd primarily operates in China.

Sihuan Pharmaceutical Holdings Group Ltd, a leading pharmaceutical company, has achieved several significant milestones. The company successfully listed its shares on the Hong Kong Stock Exchange, making it one of the first Chinese pharmaceutical companies to do so. Sihuan Pharmaceutical has established a strong presence in the global market, expanding its network of subsidiaries and joint ventures across multiple countries. The company has made substantial investments in research and development, resulting in the development of innovative drugs and therapies. Sihuan Pharmaceutical has also secured various partnerships and collaborations with renowned international pharmaceutical companies, further enhancing its growth and market position. These achievements highlight the company's commitment to advancing healthcare and delivering innovative pharmaceutical solutions.

Sihuan Pharmaceutical Holdings Group Ltd is a leading pharmaceutical company that specializes in research, development, manufacturing, and marketing of therapeutic drugs. Founded in 2001 and headquartered in Beijing, China, the company has a rich history of providing innovative and high-quality healthcare solutions. With a focus on cardiovascular and cerebrovascular diseases, oncology, and diabetes treatments, Sihuan Pharmaceutical has become a trusted brand both within China and internationally. Through strategic partnerships, advanced technology, and a commitment to excellence, the company continues to make significant contributions to the medical field, improving patient outcomes, and driving growth in the pharmaceutical industry.

The main competitors of Sihuan Pharmaceutical Holdings Group Ltd in the market are other prominent pharmaceutical companies operating in the same sector. Some notable competitors include Jiangsu Hengrui Medicine Co., Ltd., Sino Biopharmaceutical Limited, and Shanghai Pharmaceuticals Holding Co., Ltd. These companies compete with Sihuan Pharmaceutical in terms of research and development, product offerings, market presence, and overall industry reputation. Sihuan Pharmaceutical Holdings Group Ltd faces a competitive landscape as it strives to maintain its position and market share in the pharmaceutical industry.

Sihuan Pharmaceutical Holdings Group Ltd is primarily active in the pharmaceutical industry.

The business model of Sihuan Pharmaceutical Holdings Group Ltd revolves around researching, developing, manufacturing, and commercializing pharmaceutical products. The company focuses on the research and development of innovative drugs, as well as the acquisition and licensing of technologies and intellectual properties. Sihuan Pharmaceutical Group primarily operates in the Chinese pharmaceutical market, offering a diverse range of therapeutic products targeting various diseases and medical conditions. Through its rigorous clinical trials and efficient production processes, the company aims to deliver high-quality medicines to improve patients' lives. Sihuan Pharmaceutical Group's business model highlights its commitment to innovation, quality, and meeting the healthcare needs of the Chinese market.

مُعامل القيمة السوقية إلى الأرباح لـ Sihuan Pharmaceutical Holdings Group هو ١٩٨٫٢١.

مُعامِل القيمة إلى المبيعات Sihuan Pharmaceutical Holdings Group هو ٢٫١٤.

نقاط جودة AlleAktien لـ Sihuan Pharmaceutical Holdings Group هي 1/10.

المتوقعة Sihuan Pharmaceutical Holdings Group الإيرادات هي ٢٫١٧ مليارات CNY.

صافي الربح المتوقعة Sihuan Pharmaceutical Holdings Group هو ٢٣٫٤٩ مليون. CNY.

Sihuan Pharmaceutical Holdings Group Ltd is a leading Chinese pharmaceutical company based in Beijing. The company's business model includes three main areas: research and development, manufacturing, and marketing.

يوزع Sihuan Pharmaceutical Holdings Group أرباحًا قدرها ٠٫٠٥ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Sihuan Pharmaceutical Holdings Group في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـSihuan Pharmaceutical Holdings Group هو BMG8162K1137.

رمز WKN لـ Sihuan Pharmaceutical Holdings Group هو A1C72G.

الرمز المُختصر لـ Sihuan Pharmaceutical Holdings Group هو 460.HK.

خلال آخر 12 شهراً، دفعت Sihuan Pharmaceutical Holdings Group توزيعات أرباح بقيمة ٠٫٠٧ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ١٤٫٧٨ %. ومن المتوقع أن تدفع Sihuan Pharmaceutical Holdings Group خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٠٧ CNY.

نسبة توزيعات الأرباح الحالية لـ Sihuan Pharmaceutical Holdings Group هي ١٤٫٧٨ %.

Sihuan Pharmaceutical Holdings Group يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يونيو, أكتوبر, يوليو, أكتوبر.

Sihuan Pharmaceutical Holdings Group دفعت توزيعات الأرباح كل عام خلال الـ16 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٠٧ CNY. وهذا يعادل عائد توزيعات أرباح قدره ١٤٫٤٩ %.

Sihuan Pharmaceutical Holdings Group يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠٢١ CNY من Sihuan Pharmaceutical Holdings Group المُعلن عنها في ١٠‏/١٠‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٠‏/١٠‏/٢٠٢٤.

في العام 2023، وزعت Sihuan Pharmaceutical Holdings Group ٠٫١١٨ CNY كأرباح أسهم.

يتم توزيع أرباح Sihuan Pharmaceutical Holdings Group بالعملة CNY.